Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.
Amphion has a significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.
Amphion also has a specialized entity, DataTern, Inc., established to exploit IP opportunities within the Company's Partner Companies.
Presentations & Company Media
20/08/2009Amphion Interim Results 2009 (Presentation)
01/05/2009Amphion Annual Report and Accounts 2008 (Presentation)
01/01/2009Amphion Brochure (Presentation)
Related Research & Media
10/07/2009Investors Chronicle Article "Feeling Brave?" 10 July 09 (Presentation)
02/07/2009Reuters Article "Amphion CEO Sees Key Unit Beating FY Target" 2 July 2009 (Presentation)
26/10/2008Financial Times Article "Lessons Learnt from the Halls of Academia" 26 Oct 08 (Presentation)
08/02/2008Investors Chronicle Article "Brains of Britain" 8-14 Feb 08 (Presentation)
The Company’s Business and Methodology
Amphion’s business is the formation, development, operation and financing of market-leading life science and technology companies in partnership with corporations, governments, universities and entrepreneurs seeking to commercialize their intellectual property. Building upon two decades of disciplined investment and operating expertise, the building of numerous successful public and private companies, and over $20 billion in value creation, Amphion provides an opportunity to participate in both public and private early-stage investments, with a primary focus on life science and technology companies
Amphion’s Value-Creation Process
The Directors believe that the key to Amphion’s success will be the continued pursuit of the management’s successful multi-phase process for value creation.
Through its experience in building more than 30 companies, the Management Team has developed a process which generally can be broken down into distinct phases. Set out below is a representation of Amphion’s value-creation process, showing the five key phases described in more detail.
Phase I. Creation and sourcing of opportunities
Working with universities, corporations, governments and entrepreneurs seeking to commercialize their intellectual property, Amphion identifies potential company-building opportunities. Throughout the process, Amphion maximizes value creation by drawing upon a collaborative network of strategic partners built over 20 years. This network provides access to innovative technologies, enhances its ability to identify and address unmet market needs and solicits the guidance of industry and technical experts. While this network is a key source of opportunities, it also provides advice and counsel throughout the company-building process that may be technical, financial or business-related and ultimately helps the Partner Companies compete and grow.
Phase II. Down-selection of opportunities
Amphion devotes considerable time and resources to screening for the most attractive business models and proven technology platforms from the available opportunities. Potential opportunities must also provide a tractable corporate and ownership position to ensure that Amphion will be able to implement its company-building process.
Central to Amphion’s selection and investment strategy is rigorous risk management based on identifying companies with proven technology and a quantifiable, verifiable business opportunity. Amphion does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment; it looks for defensible core intellectual property and know-how for long-term competitive advantage, and growth potential in very large markets of at least $1 billion in size — and actively works with Partner Companies from the earliest stages to identify and defend core intellectual property (‘IP’).
For an example of our selection process, please click here
Phase III. Adaptive strategic positioning
Amphion then seeks to optimize its Partner Companies’ products and market positioning through refining or changing the emerging company’s market focus, business model, or strengthening the company management. Concurrently with this process, Amphion will undertake a review of the intellectual property, both strategic IP (i.e. what can be protected) and tactical IP (i.e. what can be protected) both to defend and expand the Partner Company’s competitive advantage and lead time over competitors.
Optimizing the business is often a “trial and error” process of rapid iteration and learning, with the objective of creating a company targeted on the greatest commercial opportunity that also provides a sustainable source of competitive advantage.
From this stage on, Amphion accelerates company development through a methodical and focused application of financial and human resources. The Management Team has traditionally adopted a hands-on approach with each new investment, seconding existing Amphion management to new Partner Companies in order to utilize Amphion’s accumulated knowledge in the company value-creation process, while gaining additional experience and insight which can be applied to subsequent investments.
Phase IV. Scaling and execution
In building its Partner Companies, Amphion typically provides a wide range of services including direct management, strategic planning, intellectual property planning and strategy, capital raising from Amphion’s network of investors, recruiting, business development, and other advisory services in areas such as marketing, administration, and capital markets. Amphion provides these services under an advisory agreement with the partner company and receives fees for doing so.
Amphion will then identify and recruit leading industry talent from its network of life science and technology partners and contacts to strengthen the management of the Partner Company, leading it to the next stage of development, generally an initial public offering or trade sale.
Phase V. Expansion and development
With an experienced industry team in place, Amphion continues to work with its companies over the long term, staying integrally involved with management, and seeking to influence and manage the boards and advisory committees to build value for both Amphion and Partner Company shareholders. To assist in this, Amphion will typically maintain a sizable ownership stake and measure of influence or control in the relevant Partner Company.
Throughout the company-building process, the Management Team strives to ensure that investor interests come before its own, and that the Company’s commitment to its Partner Companies, and investors, is a long-term one. The Company’s philosophy is to support its Partner Companies through difficult times, and provide additional management support when necessary to help them successfully weather downturns while improving their positioning for subsequent upturns.
Current Portfolio Summary (as it December 2011)
Intellectual Property Development
* As DataTern is 100% owned by Amphion, it is consolidated into Amphion’s financial statements.
Amphion Innovations US, Inc.
330 Madison Avenue
New York, NY 10017
Phone (212) 210 6282
Fax (212) 210 6271
UK Media please contact
Cardew Group Financial & Corporate Communications
Tim Robertson/ Jamie Milton
12 Suffolk Street London SW1Y 4HG
Phone (44) 020.7930.0777
Amphion Innovations plc
Douglas, Isle of Man
Nominated Advisor to the Company
Seymour Pierce Limited
20 Old Bailey
London, EC4M 7EN
Broker to the Company
Seymour Pierce Limited
20 Old Bailey
London, EC4M 7EN
Advisors to the Company as to English Law
15 St. Botolph Street
London, EC3A 7EE
Advisors to the Company as to Isle of Man Law
Cains Fiduciaries Limited
Douglas, Isle of Man, IM1 5PD
Auditors to the Company
Deloitte & Touche
The Old Courthouse
PO Box 250
Douglas, Isle of Man IM99 1XJ
Neville Registrars Ltd.
18 Laurel Lane
Halesowen, West Midlands B63 3DA
Public Relations UK
12 Suffolk Street
London, SW1Y 4HG